We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

51 hedge funds and large institutions have $32.9M invested in InVivo Therapeutics Holdings Corp in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 2

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

13% more funds holding

Funds holding: 45 → 51 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

35% less capital invested

Capital invested by funds: $50.4M → $32.9M (-$17.5M)

91% less call options, than puts

Call options by funds: $35K | Put options by funds: $409K

Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
11
Reduced
2
Closed
2
Calls
$35K
Puts
$409K
Net Calls
-$374K
Net Calls Change
+$83K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$715K
2
GC
Guggenheim Capital
Illinois
+$626K
3
Millennium Management
Millennium Management
New York
+$536K
4
Morgan Stanley
Morgan Stanley
New York
+$536K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$268K

Top Sellers

Rank Fund Capital Flow
1
WF
Welch & Forbes
Massachusetts
-$1.34M
2
TI
Turner Investments
Pennsylvania
-$700K
3
Goldman Sachs
Goldman Sachs
New York
-$447K
4
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
-$183K
5
MWP
MYCIO Wealth Partners
Pennsylvania
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.76M +$89.4K +1 +2%
BFA
2
BlackRock Fund Advisors
California
$4.31M +$715K +8 +17%
BIT
3
BlackRock Institutional Trust
California
$3.35M +$179K +2 +5%
WF
4
Welch & Forbes
Massachusetts
$2.98M -$1.34M -15 -28%
State Street
5
State Street
Massachusetts
$1.83M +$89.4K +1 +5%
ICM
6
IMS Capital Management
Oregon
$1.79M – – –
BBA
7
Baker Bros. Advisors
New York
$1.68M – – –
Northern Trust
8
Northern Trust
Illinois
$1.44M – – –
GC
9
Guggenheim Capital
Illinois
$1.23M +$626K +7 +78%
Morgan Stanley
10
Morgan Stanley
New York
$1.03M +$536K +6 +86%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$960K – – –
Millennium Management
12
Millennium Management
New York
$616K +$536K +6 +300%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$538K +$89.4K +1 +17%
BIM
14
BlackRock Investment Management
Delaware
$535K – – –
Goldman Sachs
15
Goldman Sachs
New York
$440K -$447K -5 -45%
TCIM
16
TIAA CREF Investment Management
New York
$391K – – –
BCM
17
Bridgeway Capital Management
Texas
$381K – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$379K +$268K +3 +150%
RJA
19
Raymond James & Associates
Florida
$344K – – –
BFM
20
Boston Financial Management
Massachusetts
$312K – – –
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$278K – – –
Charles Schwab
22
Charles Schwab
California
$246K – – –
TA
23
Teachers Advisors
New York
$221K +$89.4K +1 +50%
Group One Trading
24
Group One Trading
Illinois
$199K +$89.4K +1 +50%
Stifel Financial
25
Stifel Financial
Missouri
$176K – – –
1
2 3

NVIV Hedge Fund Activity: Q4 2016 in Review

51 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q4 2016, worth a combined $32.9M — down 35% from $50.4M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NVIV positions and 2 closed out — a net gain of 6 holders — while 11 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $715K. The largest seller was Welch & Forbes, cutting an estimated $1.34M.

  • 51 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q4 2016, up from 45 in Q3 2016.
  • Funds reported $32.9M of InVivo Therapeutics Holdings Corp stock for Q4 2016, down 35% quarter-over-quarter.
  • 8 funds opened new InVivo Therapeutics Holdings Corp positions in Q4 2016 and 2 closed out, a net change of +6 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $715K added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q4 2016 was Welch & Forbes, an estimated $1.34M sold.

Based on aggregated 13F filings for Q4 2016.